Arkema rejigs to grow specialty chem business
Arkema has restructured its business as part of its bid to generate €8bn ($10.3bn) in 2015 and become a world leader in the specialty chemicals sector.
Archives for September 19, 2012
Quintiles grants "prime site" status to Comprehensive
Quintiles has granted Comprehensive Clinical Development first refusal to work on its sponsored clinical trials.
Monsanto's plant protection team taps Complix NV for drug targeting knowhow
Agricultural technology firm Monsanto has partnered with Complix NV to develop the latter’s protein therapeutic targeting technology for crop protection applications.
Merck Millipore introduces 'open source' development at new plant
CMOs and Pharmas will own the manufacturing processes developed at a new facility as part of an ‘open source’ ethos Merck Millipore has introduced.
Cyprotex and InSphero launch predictive tox testing service using 3D micro-liver
Cyprotex and InSphero have teamed up to offer predictive drug toxicity services using 3D micro-models of liver tissue.
GM corn could soon be used to make drugs
Genetically modified corn could soon be used to mass-produce the enzymes used in rare-disease therapies, according to new research.